No Negative Psychological Impact Seen for Disclosing Aβ Status
FRIDAY, May 9, 2025-- Disclosure of amyloid-β (Aβ) status seems not have a negative psychological impact, according to a study published online May 7 in Alzheimer's & Dementia.Sapir Golan Shekhtman, from Sheba Medical Center in Ramat Gan, I...
Read more »
Pharmaceutical news
Combined Flu, SARS-CoV-2 Vaccine as Effective as Individual Vaccines for Older Adults
Three New Color Food Additives From Natural Sources Approved by FDA
FDA Warns of Possible Bacteria Contamination of Tattoo Inks
Multicancer Early Detection Screening Improves Patient Outcomes
Women Have Higher Risk for COPD Than Men, Regardless of Smoking History
Computer-Aided Design and Manufacturing Assists Jaw Reconstruction
Intraocular Inflammation More Common With Aflibercept Injections in Real-World Setting
Hyperglycemia, Insulin Resistance in Teens Linked to Worsening Cardiac Damage at Age 24
Guidelines Updated for Nonoccupational Postexposure Prophylaxis for HIV
Simultaneous Liver Transplant, Sleeve Gastrectomy Beneficial
Trump Taps Wellness Influencer Casey Means for Surgeon General
Thinking About a Tattoo? FDA Warns These Inks Could Be Dangerous
Some Cancers Increasing in People Under 50, New Report Shows
Childhood Obesity Triples Odds Of Weight Discrimination
